Nerve Agent Exposure
📧 Sign up to get email alerts when something new happens for Nerve Agent Exposure.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-11-03FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)
The FDA approved a supplemental application for DUODOTE (atropine and pralidoxime chloride) from Meridian Medical Technologies LLC, updating…
-
FDA approval · 2016-04-25FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)
The FDA approved a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector from Meridian Medical Technologies…
-
FDA approval · 2015-09-22FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)
FDA approved a supplemental application for ATNAA, the atropine and pralidoxime chloride auto-injector, enabling continued marketing under u…
-
FDA approval · 2015-02-03FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)
The FDA approved a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector, updating/expanding its labeling.
-
FDA approval · 2006-09-28FDA Approved: DUODOTE — Original Application (Meridian Medical Technologies LLC)
FDA approved DUODOTE, a dual-auto-injector containing atropine and pralidoxime chloride, for emergency treatment of organophosphate poisonin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.